Constellation Brands beat second-quarter expectations and raised its FY2027 profit forecast. That points to a stronger business outlook, despite its shares falling before the market opened.
These updates point to stronger results and a better company forecast than expected. The article also reports weak share-price trends across several periods, alongside a good growth score. Those mixed stock signals do not outweigh the company news, despite the premarket share drop.
Caribou Biosciences is exploring strategic options and plans to stop 2 cell therapy programs. Ending those programs puts its business plans in retreat.
Penguin Solutions reported fourth-quarter results above expectations and set a next-year profit-per-share forecast above estimates. Its poor quality score is a caution, but the company updates point upward.
Levi Strauss is named ahead of its report, with analysts expecting quarterly profit and sales figures. Those are estimates, not reported results, so the story gives no new company result that changes its outlook.
Follow Constellation Brands Inc. (STZ) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for STZ